Vanguard Group’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,813
| Closed | -$532K | – | 4570 |
|
|
2022
Q4 | $532K | Buy |
2,813
+1
| +0% | +$353 | ﹤0.01% | 4079 |
|
|
2022
Q3 | $1.15M | Hold |
2,812
| – | – | ﹤0.01% | 3960 |
|
|
2022
Q2 | $1.75M | Hold |
2,812
| – | – | ﹤0.01% | 3858 |
|
|
2022
Q1 | $1.74M | Sell |
2,812
-13
| -0.5% | -$9.53K | ﹤0.01% | 4013 |
|
|
2021
Q4 | $2.27M | Buy |
2,825
+18
| +0.6% | +$18.2K | ﹤0.01% | 3991 |
|
|
2021
Q3 | $3.21M | Buy |
2,807
+12
| +0.4% | +$14.5K | ﹤0.01% | 3888 |
|
|
2021
Q2 | $3.55M | Buy |
2,795
+284
| +11% | +$374K | ﹤0.01% | 3760 |
|
|
2021
Q1 | $4.1M | Buy |
2,511
+1,718
| +217% | +$3.12M | ﹤0.01% | 3630 |
|
|
2020
Q4 | $641K | Buy |
793
+3
| +0.4% | +$2.64K | ﹤0.01% | 3915 |
|
|
2020
Q3 | $818K | Buy |
790
+149
| +23% | +$238K | ﹤0.01% | 3704 |
|
|
2020
Q2 | $801K | Buy |
641
+56
| +10% | +$55.1K | ﹤0.01% | 3663 |
|
|
2020
Q1 | $611K | Buy |
585
+11
| +2% | +$10.6K | ﹤0.01% | 3628 |
|
|
2019
Q4 | $541K | Buy |
574
+4
| +0.7% | +$3.57K | ﹤0.01% | 3779 |
|
|
2019
Q3 | $554K | Buy |
570
+469
| +464% | +$392K | ﹤0.01% | 3793 |
|
|
2019
Q2 | $89K | Buy |
101
+12
| +13% | +$11K | ﹤0.01% | 4062 |
|
|
2019
Q1 | $94K | Hold |
89
| – | – | ﹤0.01% | 4018 |
|
|
2018
Q4 | $138K | Buy |
89
+68
| +324% | +$133K | ﹤0.01% | 3948 |
|
|
2018
Q3 | $43K | Hold |
21
| – | – | ﹤0.01% | 4132 |
|
|
2018
Q2 | $52K | Buy |
+21
| New | +$55.2K | ﹤0.01% | 4096 |
|
|
2018
Q1 | – | Sell |
-5
| Closed | -$22K | – | 4101 |
|
|
2017
Q4 | $22K | Sell |
5
-1
| -17% | -$6.29K | ﹤0.01% | 4048 |
|
|
2017
Q3 | $45K | Hold |
6
| – | – | ﹤0.01% | 4034 |
|
|
2017
Q2 | $39K | Sell |
6
-5
| -45% | -$37.1K | ﹤0.01% | 4038 |
|
|
2017
Q1 | $84K | Hold |
11
| – | – | ﹤0.01% | 3996 |
|
|
2016
Q4 | $103K | Buy |
11
+2
| +22% | +$18.6K | ﹤0.01% | 3969 |
|
|
2016
Q3 | $76K | Sell |
9
-10
| -53% | -$120K | ﹤0.01% | 4003 |
|
|
2016
Q2 | $173K | Hold |
19
| – | – | ﹤0.01% | 3969 |
|
|
2016
Q1 | $314K | Hold |
19
| – | – | ﹤0.01% | 3879 |
|
|
2015
Q4 | $507K | Buy |
19
+1
| +6% | +$25K | ﹤0.01% | 3828 |
|
|
2015
Q3 | $528K | Buy |
18
+4
| +29% | +$163K | ﹤0.01% | 3836 |
|
|
2015
Q2 | $342K | Hold |
14
| – | – | ﹤0.01% | 3957 |
|
|
2015
Q1 | $251K | Hold |
14
| – | – | ﹤0.01% | 3964 |
|
|
2014
Q4 | $218K | Hold |
14
| – | – | ﹤0.01% | 3889 |
|
|
2014
Q3 | $307K | Buy |
14
+1
| +8% | +$29.8K | ﹤0.01% | 3826 |
|
|
2014
Q2 | $469K | Hold |
13
| – | – | ﹤0.01% | 3701 |
|
|
2014
Q1 | $655K | Buy |
13
+1
| +8% | +$60.7K | ﹤0.01% | 3578 |
|
|
2013
Q4 | $618K | Buy |
12
+6
| +100% | +$313K | ﹤0.01% | 3539 |
|
|
2013
Q3 | $296K | Hold |
6
| – | – | ﹤0.01% | 3637 |
|
|
2013
Q2 | $319K | Buy |
+6
| New | +$340K | ﹤0.01% | 3572 |
|
Other funds holding OGEN
TRCT
IA
WWM
Vanguard Group's OGEN Position: Q1 2023 in Review
Vanguard Group sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 2,813 shares — an estimated $532K sold.
Vanguard Group first reported a position in OGEN in Q2 2013 and held it in 38 quarters. The position peaked at $4.1M in Q1 2021. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.
- Vanguard Group reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
- Vanguard Group sold 2,813 Oragenics shares in Q1 2023, an estimated $532K.
- Vanguard Group first reported a position in Oragenics in Q2 2013 and held it in 38 quarters.
- Vanguard Group's Oragenics position peaked at $4.1M in Q1 2021.
- 10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.
Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.